RKLB · sample dossier
RKLB
57/100
OutdatedGenerated Aug 8, 2026 · 6:51 PM UTC · 92 days ago
This copy is frozen (Aug 8). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierRKLB
EquityPublic company
Decision context
Recommendation
Weighed down by weak Value (20/100) and Quality (31/100) scores.
A mixed picture — no strong reason to buy or sell right now.
AlphaDog Fair Value
Executive thesis & key metrics
Executive Investment Thesis
RKLB is a launch and space systems provider trading at a market cap of $51.75B and a Price/Book ratio of 21.06. The Avoid rating reflects unprofitable operations with a Net Margin of -26.9%, P/E ratio of -258.84, and EV/EBITDA of -283.28 despite revenue growth of 63.5% YoY. The primary risk is an accounting flag with a Beneish M-score of -1.55 alongside 19.7% YoY share dilution.
Key Metrics to Watch
What changed recently
No material changes found in the last 30 days.
Why this rating
Score 57 · Hold
Data through
OutdatedMar 31, 2026
Growth 100/100 and momentum 75/100 — 1Y return 85%.
Levels unavailable — AlphaDog quantitative valuation model did not produce an estimate from comps or DCF
Re-evaluate if
- Net margin falls below -21.5% (was -26.9%)
- Revenue Growth YoY falls below 63.5%
- Revenue growth YoY drops below the current 63.5% baseline level.
Trim / reconsider if
- ROA falls below -4.3% (was -6.6%)
- Net Margin falls below -26.9%
- Net margin worsens beyond -26.9%.
Dollar levels aren’t available for this run — the view above still stands.
A Calmer Look · Devil's Advocate
What the optimistic case might still be missing about RKLB
The consensus 'Avoid' rating treats Rocket Lab as a structurally unprofitable operator, ignoring that its $(228.84)M operating loss is entirely driven by $270.72M in discretionary R&D investments for the Neutron program.
May be overlooked
Discretionary R&D expenditure of $270.72M accounts for over 100% of the $(228.84)M operating loss, masking positive underlying cash flow potential in legacy operations.
An Altman Z-score of 53.03 combined with a minimal Debt/Equity ratio of 0.06 provides robust balance sheet solvency that neutralizes near-term bankruptcy risk.
Gross margin expansion to 36.6% from 21.0% in 2023 confirms increasing manufacturing efficiency as revenue scaled 63.5% YoY to $601.8M.
Expectations look stretched
Market capitalization of $51.75B trades at an extreme Price/Book ratio of 21.1 and over 86x annual revenue ($601.8M), discounting any risk of operational delays.
Shares outstanding expanded by 19.7% YoY to offset a negative free cash flow per share of -$0.37, eroding equity value for existing holders.
Insiders executed net selling of $2.73M across 19 transactions over the past 3 months, signaling caution among leadership despite an 85.3% 1-year price gain.
Revenue growth YoY drops below the current 63.5% baseline level.
Revenue growth YoY drops below the current 63.5% baseline level.
Monitor These Triggers
3 Checkpoints · Next PrintRevenue Growth YoY (current baseline: 63.5%)
Market context
Snapshot returns at report publication
1 month
+0.3%
3 months
+5.4%
6 months
+24.9%
1 year
+85.3%
At a Glance
A large company has mixed momentum at unprofitable earnings.
Top Holders
Go deeper
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full RKLB dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.